Evidence mapPaperPMID 41504869Full record

ReviewZeitschrift fur Rheumatologie2026

[Joint patient-oriented care-First interdisciplinary S2-k guidelines on juvenile systemic lupus erythematodes].

Kirsten Mönkemöller, Catharina Schütz, Dieter Haffner, Klaus Tenbrock

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kirsten MönkemöllerKlinik für Kinder- und Jugendmedizin, Kinderkrankenhaus Amsterdamer Straße, Kinderrheumatologie, Kliniken der Stadt Köln gGmbH, Amsterdamer Straße 59, 50735, Köln, Deutschland. moenkemoellerk@kliniken-koeln.de.ORCID http://orcid.org/0000-0002-9409-441X
Catharina SchützKlinik und Poliklinik für Kinder- und Jugendmedizin, Universitäts Centrum für Chronische Immundefizienzen (UCID) Universitätsklinikum Carl Gustav Carus und Medizinische Fakultät an der TU Dresden, Dresden, Deutschland.
Dieter HaffnerKlinik für Pädiatrische Nieren‑, Leber- und Stoffwechselerkrankungen und Neuropädiatrie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Klaus TenbrockTranslationale Pädiatrische Rheumatologie und Immunologie, Klinik für Kinder- und Jugendmedizin, Uniklinik RWTH Aachen, Aachen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe treatment of systemic lupus erythematosus in childhood and adolescence (juvenile SLE) requires patient-oriented multidisciplinary care that takes the heterogeneity of the disease into account. For adults, adolescents and children, the treat to target (T2T) approach is becoming established as the basis for SLE treatment with the aim of achieving remission. This requires patients and families to be empowered to decide on treatment hand in hand with the care team through participatory decision making. The S2‑k guidelines on juvenile SLE enables a state-of-the-art care for patients with jSLE in routine clinical practice. AIM OF THE ARTICLE: The article explains the key areas of treatment management and the particular challenges in the care of jSLE patients based on these guidelines. A particular focus is placed on the actual implementation and interdisciplinarity. RESULTS AND DISCUSSION: The recommendations of these guidelines were developed based on the T2T principle and participatory decision-making process by a multiprofessional team of experts in this field in accordance with the rules of the Association of Scientific Medical Societies in Germany (AWMF). The consensus comprises 2 core statements, 11 overarching principles (OAP), 12 overarching treatment strategies (OATS) and 40 recommendations. In addition to defining treatment goals, the clinical challenge is the development of treatment strategies that are in agreement with patients and their families. There is a lack of evidence in this area. This makes it all the more important to regularly revisit and evaluate both, taking the disease damage, medication side effects, comorbidities and the achievement of a good quality of life into account.

Indexed as

Lupus Erythematosus, SystemicPatient Care TeamPatient-Centered CarePractice Guidelines as TopicRheumatologyAdolescentChildEvidence-Based MedicineFemaleGermanyHumansInterdisciplinary CommunicationIntersectoral CollaborationMalePatient ParticipationDisease activityInterdisciplinarityJuvenile SLERemissionShared decision-making

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.